P3H1
Prolyl 3-hydroxylase 1
Also known as: GROS1, LEPRE1, LEPRECAN, MGC117314, P3H1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q32P28
- Gene
- P3H1
- Ensembl
- ENSG00000117385
- Chromosome
- 1
- Canonical length
- 736 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
736 residues, UniProt reviewed canonical sequence.
>Q32P28|P3H1
1 MAVRALKLLT TLLAVVAAAS QAEVESEAGW GMVTPDLLFA EGTAAYARGD WPGVVLSMER
61 ALRSRAALRA LRLRCRTQCA ADFPWELDPD WSPSPAQASG AAALRDLSFF GGLLRRAACL
121 RRCLGPPAAH SLSEEMELEF RKRSPYNYLQ VAYFKINKLE KAVAAAHTFF VGNPEHMEMQ
181 QNLDYYQTMS GVKEADFKDL ETQPHMQEFR LGVRLYSEEQ PQEAVPHLEA ALQEYFVAYE
241 ECRALCEGPY DYDGYNYLEY NADLFQAITD HYIQVLNCKQ NCVTELASHP SREKPFEDFL
301 PSHYNYLQFA YYNIGNYTQA VECAKTYLLF FPNDEVMNQN LAYYAAMLGE EHTRSIGPRE
361 SAKEYRQRSL LEKELLFFAY DVFGIPFVDP DSWTPEEVIP KRLQEKQKSE RETAVRISQE
421 IGNLMKEIET LVEEKTKESL DVSRLTREGG PLLYEGISLT MNSKLLNGSQ RVVMDGVISD
481 HECQELQRLT NVAATSGDGY RGQTSPHTPN EKFYGVTVFK ALKLGQEGKV PLQSAHLYYN
541 VTEKVRRIME SYFRLDTPLY FSYSHLVCRT AIEEVQAERK DDSHPVHVDN CILNAETLVC
601 VKEPPAYTFR DYSAILYLNG DFDGGNFYFT ELDAKTVTAE VQPQCGRAVG FSSGTENPHG
661 VKAVTRGQRC AIALWFTLDP RHSERDRVQA DDLVKMLFSP EEMDLSQEQP LDAQQGPPEP
721 AQESLSGSES KPKDELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against P3H1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- placenta: 35 nTPM
- ovary: 20 nTPM
- smooth muscle: 19 nTPM
- blood vessel: 16 nTPM
- pituitary gland: 15 nTPM
- testis: 15 nTPM
Single-cell type
- extravillous trophoblasts: 92 nCPM
- cytotrophoblasts: 63 nCPM
- early primary spermatocytes: 44 nCPM
- hepatic stellate cells: 39 nCPM
- migrating cytotrophoblasts: 36 nCPM
- endometrial stromal cells: 35 nCPM
Immune cell
- non-classical monocyte: 27 nTPM
- myeloid DC: 24 nTPM
- intermediate monocyte: 20 nTPM
- classical monocyte: 19 nTPM
- NK-cell: 18 nTPM
- eosinophil: 17 nTPM
Brain region
- choroid plexus: 11 nTPM
- medulla oblongata: 6.4 nTPM
- cerebral cortex: 4.2 nTPM
- thalamus: 3.5 nTPM
- pons: 3.4 nTPM
- hippocampal formation: 3.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about P3H1.
Disease | AllUniProt
Conditions P3H1 is implicated in, by any mechanism.
- Osteogenesis imperfecta 8 (OI8) MIM:610915
Disease | GeneticClinVar
139 pathogenic / likely-pathogenic of 1,008 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Osteogenesis imperfecta type 8
- Osteogenesis imperfecta
- P3H1-related disorder
- Osteogenesis imperfecta type III
- Osteogenesis Imperfecta, Recessive
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.23
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bone development
- collagen fibril organization
- collagen metabolic process
- negative regulation of cell growth
- negative regulation of cell population proliferation
- negative regulation of post-translational protein modification
- positive regulation of neuron projection development
- protein folding
- protein hydroxylation
- protein stabilization
- regulation of ossification
- regulation of protein secretion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Oxoglutarate/iron-dependent dioxygenase domain
- Prolyl 4-hydroxylase, alpha subunit
- Tetratricopeptide-like helical domain superfamily
- Prolyl 3-hydroxylase
- Prolyl 4-hydroxylase alpha subunit, Fe(2+) 2OG dioxygenase domain
- Leprecan-like alpha-helical domain
- 2OG-Fe(II) oxygenase superfamily
- Leprecan family TPR-like repeat region
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of P3H1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads P3H1 as an antibody target. Whether an autoantibody or antibody against P3H1 could matter depends on whether native P3H1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
P3H1 is annotated as secreted, so native P3H1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label P3H1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...